4//SEC Filing
Coherus BioSciences, Inc. 4
Accession 0000899243-16-021654
$CHRSCIK 0001512762operating
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:05 PM ET
Size
6.3 KB
Accession
0000899243-16-021654
Insider Transaction Report
Form 4
Herman Alan C.
Chief Scientific Officer
Transactions
- Sale
Common Stock, $0.0001 par value
2016-06-01$18.67/sh−4,250$79,360→ 202,365 total
Holdings
- 300,164(indirect: By Trust)
Common Stock, $0.0001 par value
Footnotes (3)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The transaction was executed in multiple trades in prices ranging from $18.30 to $18.97, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F3]These shares are held by the Herman Trust, dated March 16, 2001, of which Reporting Person is a co-trustee.
Documents
Issuer
Coherus BioSciences, Inc.
CIK 0001512762
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001512762
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:05 PM ET
- Size
- 6.3 KB